Lipid polymer hybrid nanocarriers as a combinatory platform for different anti-SARS-CoV-2 drugs supported by computational studies-Reference-Cited by-同舟云学术

Lipid polymer hybrid nanocarriers as a combinatory platform for different anti-SARS-CoV-2 drugs supported by computational studies

Published:2021 Issue:46 Volume:11 Page:28876-28891
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Abdel-Bar Hend Mohamed¹,Abdallah Inas A.²,Fayed Marwa A. A.³^ORCID,Moatasim Yassmin⁴^ORCID,Mostafa Ahmed⁴^ORCID,El-Behairy Mohammed Farrag⁵^ORCID,Elimam Hanan⁶^ORCID,Elshaier Yaseen A. M. M.⁵^ORCID,Abouzid Khaled A. M.⁵^ORCID

Affiliation:

1. Department of Pharmaceutics, Faculty of Pharmacy, University of Sadat City, Menoufia 32897, Egypt

2. Department of Analytical Chemistry, Faculty of Pharmacy, University of Sadat City, Menoufia 32897, Egypt

3. Department of Pharmacognosy, Faculty of Pharmacy, University of Sadat City, Menoufia 32897, Egypt

4. Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt

5. Department of Organic and Medicinal Chemistry, Faculty of Pharmacy, University of Sadat City, Menoufia 32897, Egypt

6. Department of Biochemistry, Faculty of Pharmacy, University of Sadat City, Menoufia 32897, Egypt

Abstract

Drug repurposing approach to combat SARS-CoV-2: lipid polymer hybrid nanoparticles (LPH) for the delivery of azithromycin or niclosamide in combination with piroxicam.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2021/RA/D1RA04576H

Reference66 articles.

1. Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae

2. Self-injectable extended release formulation of Remdesivir (SelfExRem): A potential formulation alternative for COVID-19 treatment

3. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

4. Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV

5. Drug repurposing: progress, challenges and recommendations

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral potential of rosuvastatin and hesperidin in combination with favipiravir liposomal nanoformulations in targeting the main protease (Mpro) of SARS-CoV-2: Molecular docking, molecular dynamics and in-vitro studies;Journal of Drug Delivery Science and Technology;2024-08

2. Drug repurposing of pyrazolotriazine derivatives as potential anti-SARS-CoV-2 agents: in vitro and in silico studies;BMC Chemistry;2024-07-16

3. The Application of Biomaterials for the Vaccine, Treatment, and Detection of SARS-CoV-2;ACS Omega;2024-01-26

4. Recent Updates on Multifunctional Nanomaterials as Antipathogens in Humans and Livestock: Classification, Application, Mode of Action, and Challenges;Molecules;2023-11-20

5. Design of layer-by-layer lipid-polymer hybrid nanoparticles to elicit oral bioavailability of buspirone hydrochloride;International Journal of Polymeric Materials and Polymeric Biomaterials;2023-09-11